Regenerative Medicine

Regenerative Medicine

The global economy is at a critical crossroads with a number of interlocking challenges and crises running in parallel. The uncertainty around how Russia`s war on Ukraine will play out this year and the war`s role in creating global instability means that the trouble on the inflation front is not over yet. Food and fuel inflation will remain a persistent economic problem. Higher retail inflation will impact consumer confidence and spending. As governments combat inflation by raising interest rates, new job creation will slowdown and impact economic activity and growth. Lower capital expenditure is in the offing as companies go slow on investments, held back by inflation worries and weaker demand. With slower growth and high inflation, developed markets seem primed to enter into a recession. Fears of new COVID outbreaks and China’s already uncertain post-pandemic path poses a real risk of the world experiencing more acute supply chain pain and manufacturing disruptions this year. Volatile financial markets, growing trade tensions, stricter regulatory environment and pressure to mainstream climate change into economic decisions will compound the complexity of challenges faced. Year 2023 is expected to be tough year for most markets, investors and consumers. Nevertheless, there is always opportunity for businesses and their leaders who can chart a path forward with resilience and adaptability.

Global Regenerative Medicine Market to Reach $30.8 Billion by 2030
In the changed post COVID-19 business landscape, the global market for Regenerative Medicine estimated at US$9.6 Billion in the year 2022, is projected to reach a revised size of US$30.8 Billion by 2030, growing at a CAGR of 15.8% over the analysis period 2022-2030. Cell Therapy, one of the segments analyzed in the report, is projected to record a 16.3% CAGR and reach US$15.2 Billion by the end of the analysis period. Taking into account the ongoing post pandemic recovery, growth in the Gene Therapy segment is readjusted to a revised 15.7% CAGR for the next 8-year period.

The U.S. Market is Estimated at $2.8 Billion, While China is Forecast to Grow at 14.7% CAGR
The Regenerative Medicine market in the U.S. is estimated at US$2.8 Billion in the year 2022. China, the world`s second largest economy, is forecast to reach a projected market size of US$5.2 Billion by the year 2030 trailing a CAGR of 14.7% over the analysis period 2022 to 2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 14.4% and 13.5% respectively over the 2022-2030 period. Within Europe, Germany is forecast to grow at approximately 11.2% CAGR.

Select Competitors (Total 52 Featured) -
  • AlloSource
  • Anika Therapeutics, Inc.
  • Bioventus LLC
  • DePuy Synthes Spine, Inc.
  • Exactech, Inc.
  • Integra LifeSciences Holdings Corp.
  • LifeNet Health, Inc.
  • Medtronic, PLC
  • NovaBone Products LLC
  • NuVasive, Inc.
  • Orthofix International N.V.
  • Osiris Therapeutics, Inc.
  • Smith & Nephew plc
  • Stryker Corporation
  • Wright Medical Technology, Inc.
  • Zimmer Biomet Holdings, Inc.
Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
World Market Trajectories
Regenerative Medicine: A Preface
Recent Market Activity
An Overview of Regenerative Medicine in Bone and Joint Applications
Current and Future Analysis
Developed Markets Dominate, Developing to Drive Growth
Regenerative Medicine - Past, Present & Future
Another Revolution in the Making?
Conventional Chemical Medicine Vs Regenerative Medicine
Regenerative Medicine - Bypassing the Ethical Concerns
Regenerative Medicine Throws Up Several New Therapies
Current Global Market for Regenerative Medicine
Market Potential
Therapeutic Companies and Products in Regenerative Medicine - Current Status
Regenerative Medicine – Global Key Competitors Percentage Market Share in 2022 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2022 (E)
Impact of Covid-19 and a Looming Global Recession
2. FOCUS ON SELECT PLAYERS
AlloSource (US)
Anika Therapeutics, Inc. (US)
Bioventus LLC (US)
DePuy Synthes Companies (US)
DePuy Synthes Spine, Inc. (US)
Exactech, Inc. (US)
Integra LifeSciences Holdings Corp. (US)
LifeNet Health, Inc. (US)
Medtronic, plc (Ireland)
NovaBone Products LLC (US)
NuVasive, Inc. (US)
Orthofix International N.V. (Netherlands)
Osiris Therapeutics, Inc. (US)
Smith & Nephew plc (UK)
Stryker Corporation (US)
Wright Medical Technology, Inc. (US)
Zimmer Biomet Holdings, Inc. (US)
3. MARKET TRENDS & DRIVERS
A Combination of Factors to Drive Regenerative Medicine Market
Burgeoning Global Population Offers Significant Growth Opportunities
Aging Global Population: Need for New Effective Treatments
Increasing Healthcare Spending in Emerging Markets: Opportunities in Store
Government Support and Increased Private Sector Participation
Investment and Funding Landscape
Major M&A Activity and Strategic Alliances in Regenerative Medicine: 2011-2016
Recent Advancements in the Science of Regenerative Medicine
Advanced Ceramics Gaining Preeminence in Regenerative Medicine Field
3D Organ & Tissue Printing: Still in Early Stages
Nanotechnology in Regenerative Medicine
Issues to be Sorted Out
Need for New Scientific and Technological Standards
Standardized Guidelines
Clinical Translation - Collaboration of Multidisciplinary Skills is Essential
The Question of Apt Business Models - The Service and Product Approach
Autologous or Service Approach Preferred by European Firms
Allogenic or Product Approach - Slow to Develop
Regenerative Medicine Requires Improved Biomaterials
Investors Wary of Funding Regenerative Medicine
Regenerative Medicine Field Lags Behind Due to Segregated Focus
Challenges Encountered by Regenerative Medicine
Scientific and Technological Challenges
Barriers in Sharing Intellectual Property Rights
Viable Manufacturing Technologies and Skilled Personnel Crucial
Strict Regulations Push up Operational Costs
Challenges Facing Autologous Cell Therapies
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 2: World Historic Review for Regenerative Medicine by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 3: World 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2014, 2023 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 5: World Historic Review for Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 6: World 16-Year Perspective for Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 7: World Recent Past, Current & Future Analysis for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 8: World Historic Review for Gene Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 9: World 16-Year Perspective for Gene Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 11: World Historic Review for Tissue Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 12: World 16-Year Perspective for Tissue Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 13: World Recent Past, Current & Future Analysis for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 14: World Historic Review for Other Product Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 15: World 16-Year Perspective for Other Product Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 17: World Historic Review for Biologically Derived by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 18: World 16-Year Perspective for Biologically Derived by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 19: World Recent Past, Current & Future Analysis for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 20: World Historic Review for Synthetic by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 21: World 16-Year Perspective for Synthetic by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 23: World Historic Review for Genetically Engineered by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 24: World 16-Year Perspective for Genetically Engineered by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 25: World Recent Past, Current & Future Analysis for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 26: World Historic Review for Other Material Types by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 27: World 16-Year Perspective for Other Material Types by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 29: World Historic Review for Musculoskeletal by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 30: World 16-Year Perspective for Musculoskeletal by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 31: World Recent Past, Current & Future Analysis for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 32: World Historic Review for Oncology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 33: World 16-Year Perspective for Oncology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 34: World Recent Past, Current & Future Analysis for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 35: World Historic Review for Cardiovascular by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 36: World 16-Year Perspective for Cardiovascular by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 37: World Recent Past, Current & Future Analysis for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 38: World Historic Review for Dermatology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 39: World 16-Year Perspective for Dermatology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 40: World Recent Past, Current & Future Analysis for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 41: World Historic Review for Ophthalmology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 42: World 16-Year Perspective for Ophthalmology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 43: World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 44: World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 45: World 16-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2014, 2023 & 2030
TABLE 46: World Regenerative Medicine Market Analysis of Annual Sales in US$ Million for Years 2014 through 2030
III. MARKET ANALYSIS
UNITED STATES
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2023 (E)
TABLE 47: USA Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 48: USA Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 49: USA 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
TABLE 50: USA Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 51: USA Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 52: USA 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
TABLE 53: USA Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 54: USA Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 55: USA 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
CANADA
TABLE 56: Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 57: Canada Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 58: Canada 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
TABLE 59: Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 60: Canada Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 61: Canada 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
TABLE 62: Canada Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 63: Canada Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 64: Canada 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
JAPAN
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2023 (E)
TABLE 65: Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 66: Japan Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 67: Japan 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
TABLE 68: Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 69: Japan Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 70: Japan 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
TABLE 71: Japan Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 72: Japan Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 73: Japan 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
CHINA
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2023 (E)
TABLE 74: China Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 75: China Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 76: China 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
TABLE 77: China Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 78: China Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 79: China 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
TABLE 80: China Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 81: China Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 82: China 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
EUROPE
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2023 (E)
TABLE 83: Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2022 through 2030 and % CAGR
TABLE 84: Europe Historic Review for Regenerative Medicine by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 85: Europe 16-Year Perspective for Regenerative Medicine by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2014, 2023 & 2030
TABLE 86: Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 87: Europe Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 88: Europe 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
TABLE 89: Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 90: Europe Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 91: Europe 16-Year Perspective for Regenerative Medicine by Material Type - Percentage Breakdown of Value Sales for Biologically Derived, Synthetic, Genetically Engineered and Other Material Types for the Years 2014, 2023 & 2030
TABLE 92: Europe Recent Past, Current & Future Analysis for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 93: Europe Historic Review for Regenerative Medicine by Application - Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 94: Europe 16-Year Perspective for Regenerative Medicine by Application - Percentage Breakdown of Value Sales for Musculoskeletal, Oncology, Cardiovascular, Dermatology, Ophthalmology and Other Applications for the Years 2014, 2023 & 2030
FRANCE
Regenerative Medicine Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2023 (E)
TABLE 95: France Recent Past, Current & Future Analysis for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 96: France Historic Review for Regenerative Medicine by Product Type - Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR
TABLE 97: France 16-Year Perspective for Regenerative Medicine by Product Type - Percentage Breakdown of Value Sales for Cell Therapy, Gene Therapy, Tissue Engineering and Other Product Types for the Years 2014, 2023 & 2030
TABLE 98: France Recent Past, Current & Future Analysis for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types - Independent Analysis of Annual Sales in US$ Million for the Years 2022 through 2030 and % CAGR
TABLE 99: France Historic Review for Regenerative Medicine by Material Type - Biologically Derived, Synthetic, Genetically Engineered and Other Material Types Markets - Independent Analysis of Annual Sales in US$ Million for Years 2014 through 2021 and % CAGR

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings